Droperidol

FDA Approved: * February 29, 1988
Pharm Company: * HOSPIRA
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Droperidol Overview

Droperidol /droprIdl/ (Inapsine, Droleptan, Dridol, Xomolix, Innovar [combination with fentanyl]) is an antidopaminergic drug used as an antiemetic (that is, to prevent or treat nausea) and as an antipsychotic. Droperidol is also often used as a sedative in intensive-care treatment. Contents 1 History 2 Medical use 3 Black box warning 4 Side effects 5 Chemistry 6 References 7 Further reading History Discovered at Janssen Pharmaceutica in 1961, droperidol is a butyrophenone which acts...

Read more Droperidol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Droperidol

Recent Droperidol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Droperidol: (4 results)

Sorted by National Drug Code

• 0409-1187 Droperidol 2.5 mg/ml Intramuscular; Intravenous Injection, Solution by Hospira, Inc.
• 0517-9702 Droperidol 2.5 mg/ml Intramuscular; Intravenous Injection, Solution by American Regent, Inc.
• 52584-041 Droperidol 2.5 mg/ml Intramuscular; Intravenous Injection, Solution by General Injectables & Vaccines, Inc
• 55154-5706 Droperidol 2.5 mg/ml Intramuscular; Intravenous Injection, Solution by Cardinal Health

Other drugs which contain Droperidol or a similar ingredient: (1 result)

• INAPSINE Droperidol